PHIO PHARMACEUTICALS CORP. Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PHIO PHARMACEUTICALS CORP. stock issued during period, shares, employee stock purchase plans for the quarter ending 2015-06-30 was 0.00 shares.
- PHIO PHARMACEUTICALS CORP. stock issued during period, shares, employee stock purchase plans for the quarter ending 2014-06-30 was 0.00 shares.
- PHIO PHARMACEUTICALS CORP. stock issued during period, shares, employee stock purchase plans for fiscal 2019 was 1.00 shares.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2019-12-31 | 1.00 shares 10-K · filed 2020-03-26 | |
| 2015-06-30 | 0.00 shares 10-Q · filed 2015-08-12 | |
| 2014-06-30 | 0.00 shares 10-Q · filed 2015-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |